IRCCS Fondazione Policlinico Universitario A. Gemelli

Medicine & Life Sciences

1. Italy 100%
2. Therapeutics 99%
3. Neoplasms 90%
4. Coronavirus 88%
5. Multicenter Studies 83%
6. Pandemics 76%
7. Survival 74%
8. Systematic Reviews 62%
9. Ovarian Neoplasms 62%
10. SARS Virus 60%
11. Radiotherapy 51%
12. Mortality 45%
13. Mutation 44%
14. Safety 44%
15. Drug Therapy 42%
16. Biomarkers 42%
17. Retrospective Studies 41%
18. Registries 41%
19. Recurrence 40%
20. Observational Studies 40%
21. Infections 40%
22. Meta-Analysis 39%
23. Guidelines 37%
24. Progression-Free Survival 36%
25. Lung 35%
26. Pediatrics 35%
27. Child 34%
28. Non-Small Cell Lung Carcinoma 33%
29. Inflammatory Bowel Diseases 32%
30. Cohort Studies 32%
31. Confidence Intervals 31%
32. Endometrial Neoplasms 30%
33. Population 30%
34. Neoplasm Metastasis 30%
35. Medical Oncology 29%
36. Genes 29%
37. Prospective Studies 28%
38. B-Cell Chronic Lymphocytic Leukemia 28%
39. Phenotype 28%
40. Pharmaceutical Preparations 27%
41. Sarcopenia 26%
42. Breast Neoplasms 26%
43. Liver 25%
44. Frailty 24%
45. Randomized Controlled Trials 24%
46. Gastrointestinal Microbiome 24%
47. Colorectal Neoplasms 24%
48. Quality of Life 23%
49. Immunotherapy 23%
50. Renal Cell Carcinoma 23%
51. Databases 23%
52. Uterine Cervical Neoplasms 23%
53. Incidence 23%
54. Hepatocellular Carcinoma 22%
55. Transplants 22%
56. Muscles 21%
57. Consensus 21%
58. Platinum 21%
59. Bevacizumab 21%
60. Comorbidity 21%
61. Severe Acute Respiratory Syndrome 21%
62. pembrolizumab 20%
63. Brachytherapy 20%
64. Odds Ratio 20%
65. Propensity Score 20%
66. olaparib 19%
67. Elderly 19%
68. Intensive Care Units 19%
69. Disease Progression 19%
70. Inflammation 18%
71. Clinical Trials 18%
72. Delivery of Health Care 18%
73. Pneumonia 18%
74. Carcinoma 18%
75. Disease Outbreaks 18%
76. Alzheimer Disease 18%
77. Brain 18%
78. Equipment and Supplies 17%
79. Precision Medicine 17%
80. Rectal Neoplasms 17%
81. Microbiota 17%
82. Duchenne Muscular Dystrophy 17%
83. Thorax 17%
84. Multiple Sclerosis 17%
85. Cognitive Dysfunction 17%
86. Crohn Disease 16%
87. Pancreatic Neoplasms 16%
88. Prostatic Neoplasms 16%
89. Skin 16%
90. Hematology 16%
91. Lymph Nodes 16%
92. Health 16%
93. Hemorrhage 16%
94. Stents 15%
95. Hysterectomy 15%
96. Proteins 15%
97. Glioblastoma 15%
98. Fecal Microbiota Transplantation 15%
99. Amyloidosis, Hereditary, Transthyretin-Related 15%
100. Hematopoietic Stem Cell Transplantation 15%